I now one part of the liquidation is NeuroArm. If NeuroArm is different that their SYMBIS MRI robot then ok, maybe we have a chance. If SYMBIS is under the NeuroArm umbrella, I can't imagine what value in the world IMRIS maintains after the sell off.